The impact of active surveillance of patients at risk for infection with vancomycin-resistant enterococci (VRE) was examined, and VRE bacteremia rates and the degree of VRE clonality in 2 similar neighboring hospitals were compared. Hospital A did not routinely screen patients for VRE rectal colonization; hospital B actively screened high-risk patients. Retrospective observations were made over the course of 6 years, beginning when initial VRE bloodstream isolates were recovered at each institution. The rate of VRE bacteremia was 2.1-fold higher at hospital A, and the majority of hospital A isolates were clonally related: 4 clones were responsible for infection in 175% of patients with VRE bacteremia, and isolates from 30% of patients were from the most common clone. The 4 most common clones at hospital B were responsible for infection in 37% of patients, and isolates from 14.5% of patients were from the most common clone. Lower VRE bacteremia rates and a more polyclonal population, representing less horizontal transmission, may result from routine screening of patients who are at risk for VRE and prompt contact isolation of colonized individuals.
documented difficulties in controlling VRE emphasize the importance of defining effective infection-control strategies [3] [4] [5] , although assessing the overall outcome of an intervention can be difficult [6] .
There is evidence that the occurrence of some types of nosocomial infections, including those caused by VRE, can be reduced through routine surveillance for colonization in high-risk patients and the contact isolation of colonized or infected patients [7] [8] [9] [10] [11] [12] . Until this date, no interinstitution comparative studies of infection-control practices have been made.
In 1999, a large tertiary care teaching hospital reported isolation of VRE from blood samples from 218 patients during the first 6 years after the initial isolation of VRE (hospital A) [13] . We noted that, in a similar institution located nearby, VRE were isolated from blood samples from only 72 patients during the first 6 years after the initial isolation of VRE (hospital B). Hospital B had been using a comprehensive infectioncontrol program that included routine surveillance for VRE colonization in high-risk patients and contact isolation of colonized or infected patients, whereas hospital A did not use such measures. We hypothesize that routine screening for colonization and contact isolation of highrisk patients, as implemented by hospital B, can account for the dramatic differences in VRE bacteremia rates. We used 2 measures to assess outcome: the number of VRE bloodstream isolates per 100,000 patient-days and the degree of clonality (indicating degree of horizontal spread), as determined by PFGE.
METHODS

Setting.
Hospital A has 700 beds (68 beds in the intensive care unit) and 35,000 admissions per year and did not routinely screen patients for VRE rectal colonization during the period of observation. Hospital B has 683 beds (96 beds in the intensive care unit) and 34,000 admissions per year and actively screens high-risk patients. Both are tertiary care centers located ∼7 km apart in a large metropolitan area. Both are the major teaching facilities affiliated with 2 different universities.
Period of investigation and inclusion criteria. Retrospective observations took place over the course of a 6-year period, beginning with initial isolation of VRE from patients' blood samples at each institution. The first bloodstream isolate of VRE at hospital B was identified in July 1992. All patients with VRE bloodstream isolates detected from July 1992 through June 1998 were included in the study. These results were compared with those of a previously published report from hospital A [13] , at which the first VRE bloodstream isolate was identified in November 1990. So that we could compare VRE rates during two 6-year time periods, the first patient from hospital A was excluded from the study, and the analysis included VRE bloodstream isolates identified from January 1991 through December 1996. In both hospitals, only the first isolate from patients with multiple VRE-positive cultures was included in the analysis.
Demographic characteristics of patients and hospitals. Patient medical records from hospital B were reviewed for age, sex, ward, dates of stay, referral from a long-term care facility, primary diagnoses, and primary procedures; data on in-hospital mortality were also collected. Chart reviews for this study were approved by the institutional review board of Northwestern University (Chicago). Results were compared with data from hospital A, as reported in Kim et al. [13] , with permission of the authors. The budget offices at each institution were queried for total adult patient-days, which excluded newborns and pediatric and maternity patients, for the two 6-year periods of study. The number of admissions per year and the number of beds for hospital B, as well as the annual number of surgical procedures for both institutions, were obtained from the hospital Web sites [14, 15] . Vancomycin use data for hospital B during the 6-year period was obtained from the hospital pharmacy database. Vancomycin use data for hospital A during 1991-1996, the number of admissions per year, and the number of beds at hospital A were obtained from a study published elsewhere [13] .
Active surveillance. Beginning in early 1993, hospital B obtained weekly rectal swabs from all patients who received care in high-risk units (hematology-oncology, transplant, and intensive care). Weekly swabs were collected until VRE had not been detected in any new patients for 3 consecutive weeks, at which point the frequency was reduced to monthly surveillance. Non-high-risk nursing units were subjected to weekly surveillance only when a clinical case of VRE infection was detected on that unit; surveillance continued until no new cases had been detected for 3 consecutive weeks and then was discontinued until a new clinical case was detected. All patients admitted from a nearby rehabilitation center (where VRE rates were high) were placed into contact isolation, where they remained, unless the rectal swab culture demonstrated no VRE.
All routine surveillance swabs were plated to selective media within 8 h after receipt by the laboratory. The medium consisted of tryptic soy agar base with 5% sheep cells containing vancomycin, amphotericin B, ceftazidime, and clindamycin [16] , which allowed growth of VRE and resistant gram-negative organisms while inhibiting most other microbes [17] . The plates were incubated at 35ЊC in an atmosphere of 5%-10% CO 2 and examined at 24 and 48 h. Catalase-negative gram-positive cocci were speciated with traditional biochemical tests by the agar replicator method [18] . Susceptibility testing was performed using standard agar dilution methods [19] . When VRE were detected, the microbiology technologist immediately called the nursing unit to indicate that the patient required contact isolation. An infection-control practitioner was also notified of this result.
Strain typing. As part of the infection-control program at hospital B, 70 of 72 initial patient VRE isolates had been subjected to restriction endonuclease analysis, using methods published elsewhere [20] , but these data were not included in the analysis in the present study. For the present study, molecular typing was performed using PFGE. The initial VRE bloodstream isolates from 62 of 72 patients at hospital B, obtained from July 1992 through June 1998, were available for PFGE and were recovered from storage at Ϫ70ЊC. Enterococcal genomic DNA was prepared using the GenePath System Group 1 Reagent Kit (Bio-Rad Laboratories). Samples were digested with SmaI, and DNA fragments were resolved in 1% agarose gels by use of the GenePath System rapid procedure protocol (Bio-Rad Laboratories). DNA fragments of 25-400 kb were separated using protocol 13, a single-state mode that best separates bands ranging from 25-400 kb. It produces a nonlinear ramp of 1.0-23.0 s for 18.5 h using a switch angle of 120Њ, voltage of 6 V/cm, and temperature of 14ЊC. The similarity between isolates was determined by visual comparison of photographs of isolate-banding patterns stained with Sybr Green Downloaded from https://academic.oup.com/cid/article-abstract/37/7/921/422181 by guest on 05 December 2018 (Molecular Probes). Isolates were considered to be distinct if their PFGE patterns differed by 16 bands (designated by letters). Subtypes were defined as strains that differed by 2-6 bands (designated by numbers) [21] .
Hospital A had performed PFGE typing of their VRE isolates as described elsewhere [13] . To summarize, enterococcal DNA digested with SmaI was separated in 1% agarose using a CHEFMapper (Bio-Rad Laboratories). This electrophoresis system used a multistate mode of 2 blocks of ramping conditions: the first used a linear ramp of 2-7 s for 11 h, and the second used a linear ramp of 7-35 s for 15 h. This system also used a switch angle of 120Њ, voltage of 6 V/cm, and temperature of 14ЊC. Isolates were considered to be of distinct strain types if their PFGE patterns differed by 16 bands. Subtypes were defined as strains that differed by 2-6 bands.
Statistical analysis. Statistical analysis was performed using Statistics Calculator, version 5.0 (Stat Pac). To determine whether there was a difference between 2 mean results from hospital A and hospital B, an independent-groups t test comparing means was performed, assuming unequal variances between the samples. To determine whether there was a difference between 2 percentage results from hospital A and hospital B, a 2-sample t test comparing percentages was performed. A 2-tailed t statistic р.05 was considered to be statistically significant. Table 1 highlights the characteristics of each hospital during the first 6 years after the initial case of VRE bacteremia. Both institutions performed numerous surgical procedures, including solid-organ transplantations. The mean defined daily dose of vancomycin per 1000 patient-days per year used during the study period at hospital A was not significantly different from that at hospital B ( ). P p .335 Table 2 shows annual numbers of patients with VRE bacteremia per 100,000 patient-days for the first 6 years after the first case of VRE bacteremia at each institution. During the period from 1 January 1991 through 31 December 1996, hospital A reported 218 patients with VRE bacteremia. Using 1,271,715 patient-days as the denominator, we calculated that hospital A had 17.1 patients with VRE bloodstream isolates per 100,000 patient-days during the 6-year study period. During the period from 1 July 1992 through 30 June 1998, hospital B identified 72 patients with VRE bacteremia. Using 875,730 patient-days as the denominator, we calculated that hospital A had 8.2 patients with VRE bloodstream isolates per 100,000 patient-days during the 6-year study period. When the analysis was corrected for patient-days, hospital A had 2.1-fold more cases of VRE bacteremia than did hospital B. Table 3 shows the clinical and demographic characteristics of the patients with VRE bloodstream isolates at each institution. Study patients were primarily elderly, with no significant differences in sex or average age between institutions. The mean hospital stay was significantly shorter at hospital B than at hospital A ( ), but the mean time between admission P р .01 and the first blood culture positive for VRE was comparable. Nearly one-half of the patients at hospital A were in the intensive care unit at the time of onset of VRE bacteremia; the proportion was significantly lower (29.1%) at hospital B. A minority of the VRE-infected patients had been referred from long-term care facilities, and this proportion was not significantly different between institutions.
RESULTS
Approximately one-fourth of the patients with VRE bacteremia at both institutions had undergone organ transplantation, but the types of transplantations performed differed significantly between institutions. At hospital A, most were solidorgan (primarily liver [17%]) transplantations, and, at hospital B, most were bone marrow transplantations. One or more comorbid conditions were present in most patients who developed VRE bacteremia, but the proportions of patients with cancer ( ), cardiovascular disease ( ), and diabetes P р .01 P р .01 mellitus ( ) were significantly higher at hospital B. More P р .01 patients with VRE bacteremia had undergone abdominal operations at hospital A than at hospital B (
), but me-P р .01 chanical ventilatory support was more common among patients with VRE bacteremia at hospital B than among those at hospital A ( ). No differences were seen in the proportion of P p .03 patients who had undergone biliary, endoscopic, or hemodialysis procedures between institutions in this population. The overall rates of in-hospital mortality and mortality within 48 h of positive culture for patients with VRE bacteremia in the 2 institutions were similar. Figure 1 shows the proportion of each PFGE strain type at each institution during the 6-year study periods. VRE blood isolates from 182 of 218 patients with VRE bacteremia from hospital A (and an additional patient who had VRE bacteremia in 1990) revealed 10 strain types of Enterococcus faecium, 5 strain types of Enterococcus faecalis, and 9 strain types of other enterococcal species. PFGE typing of VRE blood isolates from 62 of 72 patients with VRE bacteremia from hospital B revealed 22 strain types of E. faecium, 8 strain types of E. faecalis, and 1 strain type of another enterococcal species. Isolates from 10 patients at hospital B were unavailable for PFGE typing. Of those 10 isolates, 8 isolates had been previously typed by REA and shown to be of 6 different REA types (data not shown and not included in the analysis).
At hospital A, the majority of VRE that caused bloodstream infections were clonally related. The 4 most predominant clones were responsible for infection in 175% of all patients with VRE bloodstream isolates, and isolates from 30% of patients were from the most common clone. VRE causing bloodstream infections were more polyclonal at hospital B than at hospital A. NOTE. For hospital A, the total no. of patients was 218; the total no. of patient-days was 1,271,715; and the total no. of patients per 100,000 patient-days was 17.1. For hospital B, the totals were 71, 875,730, and 8.2, respectively. Data on patient-days were obtained from the budget offices of each institution; these data exclude maternity and pediatric patients and newborns.
a Study year begins on the first day of the month that the first (hospital A) or second (hospital B) patient with a VRE blood isolate was identified at each institution. The 4 isolates from 1 patient identified in 1990 at hospital A were excluded from this comparison.
The 4 most predominant clones at hospital A were responsible for infection in 37% of all patients with VRE bloodstream isolates, and isolates from 14.5% of patients were from the most common clone. Figure 2 shows the unique PFGE patterns of representative VRE blood isolates from patients at hospital B.
DISCUSSION
Hospital A had a 2.1-fold higher rate of VRE bacteremia and a more polyclonal VRE population than did hospital B during the first 6 years after the initial case of VRE bacteremia at each institution. Interestingly, the 2 hospitals evaluated in this study are strikingly similar in location, volume of patients (admissions per year), size (number of beds), surgical procedures performed, and severity of patient illness. Although previous studies have shown a correlation between vancomycin use and VRE infection rates [13, 22, 23] , vancomycin use did not account for the difference in VRE bacteremia rates at these 2 institutions. Although it is possible that use of other antimicrobials that were not measured (i.e., cephalosporins) could account for difference in VRE infection rates, this would not explain the difference in the degree of monoclonality.
Demographic and clinical characteristics of study patients were similar to those in other investigations of infections caused by VRE [22, 24] , but there were some interinstitutional differences in types of diseases and procedures in study patients. The proportion of patients with VRE who were solid-organ (predominantly liver) transplant recipients was significantly higher at hospital A than at hospital B. Although liver transplantation was less frequent at hospital B, the bone marrow transplantation service was very active, and a significantly higher proportion of patients with VRE bacteremia had received bone marrow transplants at this institution. Other reports have suggested that both liver [23, 25] and bone marrow [26, 27] transplants are risk factors for VRE bacteremia. It is possible that a higher number of liver transplantations accounts for a very small part of the increase in VRE bacteremia rates at hospital A, but this would not explain the greater degree of monoclonal spread at that hospital. The higher proportion of abdominal operations undergone by patients with VRE bloodstream isolates at hospital A may also partially be explained by the higher number of liver transplantations. Although a higher proportion of patients with VRE bacteremia at hospital B required mechanical ventilatory support, patients who had VRE bacteremia at hospital A stayed in the hospital significantly longer than did such patients at hospital B. However, there was no significant difference between institutions in time from admission to first blood culture positive for VRE or in mortality in this patient population. Perhaps this reflects the fact that nearly one-half of the patients with VRE bacteremia at hospital A were in the intensive care unit at the time of onset of bacteremia-twice the proportion at hospital B. Because intensive care unit patients often require longer hospital stays, it is not surprising that patients with VRE bacteremia at hospital A had longer stays. Because intensive care unit patients were considered to be at high risk of VRE bacteremia, they were routinely screened for VRE at hospital B (but not at hospital A); we believe that this limited the horizontal spread in the intensive care unit at hospital B, further demonstrating the benefit of routine screening for VRE to detect and isolate VRE-colonized patients early.
The practice of routine screening of patients at risk for VRE at hospital B, but not hospital A, was a notable difference relevant to this study. By preventing new colonization from occurring, it follows logically that new infections (which were fatal in ∼30% of patients) would also be prevented.
Molecular typing results of PFGE from each institution support the concept that a hospital with an active "screen and isolate" program would have less horizontal transmission or common-source spread of VRE. At both institutions, 195% of the cases of VRE bacteremia were caused by either E. faecium or E. faecalis. However, more of the VRE bloodstream isolates were clonally related at hospital A than at hospital B. The more monoclonal pattern of isolates at hospital A suggests that horizontal or common-source spread was the primary means of dissemination, whereas the more polyclonal pattern of isolates at hospital B suggests that introduction of new strains was the major mode of dissemination. These data suggest that lower VRE bloodstream isolation rates and a more polyclonal population may result from routine screening of patients at risk for VRE and prompt contact isolation of colonized patients.
Although these data are compelling, there are limitations to the definitive conclusions that can be drawn from them. The clinical data from hospital A [13] were obtained from archived, computerized patient records of 83% of eligible patients. The hospital B investigators used manual chart review to obtain their data from 70% of eligible patients. One investigator using one method of epidemiological investigation on 100% of the study patients would be ideal for the most accurate comparison. In addition, because VRE was introduced into each institution at a different time, a direct comparison during the same time period was not possible. An ideal comparison would have been one that included 2 similar institutions that experienced the introduction of VRE at precisely the same time, but such a study was not possible.
Furthermore, although molecular typing was interpreted using the same criteria, PFGE typing was performed separately, using slightly different techniques, by each institution and not side-by-side in the same laboratory with a single investigator's interpretation. However, it is unlikely that performing PFGE in the ideal setting would have resulted in a different conclusion. In fact, the PFGE methods used by hospital A may have allowed slightly more discriminatory typing of enterococci than did the conditions used by hospital B, particularly the higher molecular weights (i.e., top portion of the gel). Thus, the differences in clonality observed between institutions in this study may have actually been slightly underestimated.
Although some limitations are inherent in the design of this study, the results are still informative. Our study provides the only (to our knowledge) interinstitution comparative data on the infection-control practice of active surveillance. Our data suggest that the hospital that practiced routine, active surveillance for VRE colonization in high-risk patients had a 12-fold lower rate of VRE bacteremia and a far more polyclonal VRE population-which suggests less horizontal spread throughout the hospital-than did a nearby hospital in the same city with similar demographics that did not perform routine surveillance for VRE colonization in high-risk patients. The results of this study support a growing body of literature that shows the benefit of hospital infection-control programs that use routine, active screening and contact isolation programs to minimize the spread of resistant bacteria in hospitals [7] [8] [9] [10] [11] 28] .
